Clinical Trials on Subcutaneous Fat Cell Disruption in United Kingdom
Total 1472 results
-
Northwestern UniversityCompleted
-
Riverchase DermatologyAllerganUnknownSubcutaneous FatUnited States
-
Caliway Biopharmaceuticals Co., Ltd.RecruitingSubcutaneous FatUnited States
-
Caliway Biopharmaceuticals Co., Ltd.Active, not recruitingSubcutaneous FatUnited States
-
Caliway Biopharmaceuticals Co., Ltd.CompletedSubcutaneous FatUnited States
-
Cynosure, Inc.Completed
-
Cynosure, Inc.Completed
-
Caliway Biopharmaceuticals Co., Ltd.CompletedSubcutaneous FatUnited States, Australia
-
CAO Group, Inc.CompletedAbdominal Subcutaneous FatUnited States
-
BodyAesthetic Research CenterCompletedAbdominal Subcutaneous FatUnited States
-
Kythera BiopharmaceuticalsCompleted
-
Washington University School of MedicineCompletedDetermine Immune Cell Types in Subcutaneous Adipose TissueUnited States
-
Venus ConceptWithdrawn
-
10xBio, LLCTherapeutics, Inc.Active, not recruitingSubcutaneous Fat DisorderUnited States
-
Beam Therapeutics Inc.Not yet recruitingAlpha 1-Antitrypsin DeficiencyUnited Kingdom
-
Wave Life Sciences Ltd.RecruitingAlpha-1 Antitrypsin DeficiencyUnited Kingdom
-
Alnylam PharmaceuticalsTerminatedAntitrypsin Deficiency Liver DiseaseUnited Kingdom
-
Alnylam PharmaceuticalsTerminatedZZ Type Alpha-1 Antitrypsin Deficiency Liver DiseaseUnited Kingdom
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Seagen Inc.WithdrawnBrentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell LymphomaRecurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated T-Cell Lymphoma | Recurrent Follicular T-Cell Lymphoma | Recurrent Hepatosplenic T-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
University of NottinghamNottingham University Hospitals NHS TrustRecruitingChronic Obstructive Pulmonary Disease | Alpha 1-Antitrypsin DeficiencyUnited Kingdom
-
Arrowhead PharmaceuticalsActive, not recruitingAlpha 1-Antitrypsin DeficiencyAustria, Germany, United Kingdom
-
Arrowhead PharmaceuticalsTerminatedAlpha-1 Antitrypsin DeficiencyAustralia, Netherlands, Germany, United Kingdom
-
Kamada, Ltd.Syneos HealthRecruitingAlpha 1-Antitrypsin DeficiencyUnited Kingdom, Sweden, Ireland, Netherlands, Belgium, Finland
-
Grifols Therapeutics LLCCompletedAlpha 1-Antitrypsin DeficiencyDenmark, Sweden, United Kingdom
-
Z Factor LimitedHammersmith Medicines Research; Centessa Pharmaceuticals plcTerminatedAlpha1 Anti-Trypsin DeficiencyUnited Kingdom
-
Institute of Child HealthUnknown
-
Grifols Therapeutics LLCCompletedAlpha 1-Antitrypsin DeficiencyUnited States, United Kingdom
-
King's College LondonSickle Cell SocietyActive, not recruitingSickle Cell DiseaseUnited Kingdom
-
National Cancer Institute (NCI)CompletedSubcutaneous Panniculitis-Like T-Cell Lymphoma | T-Cell Peripheral Lymphoma | Gamma Delta Hepatosplenic T-Cell Lymphoma | NK T-Cell LymphomaUnited States
-
Inhibrx, Inc.CompletedAlpha-1 Antitrypsin Deficiency | AATDUnited States, New Zealand, United Kingdom
-
King's College Hospital NHS TrustKing's College London; University College London Hospitals; University of Sheffield and other collaboratorsRecruitingSickle Cell DiseaseUnited Kingdom
-
PfizerTerminatedSickle Cell DiseaseUnited Kingdom
-
Baxalta now part of ShireTerminatedSickle Cell DiseaseUnited Kingdom
-
Imperial College Healthcare NHS TrustImperial College LondonCompletedSickle Cell DiseaseUnited Kingdom
-
Global Blood TherapeuticsCompleted
-
Guy's and St Thomas' NHS Foundation TrustCompleted
-
University College, LondonGuy's and St Thomas' NHS Foundation Trust; The Whittington Hospital NHS TrustUnknownSickle Cell DiseaseUnited Kingdom
-
Global Blood TherapeuticsCompletedSickle Cell Disease | Healthy SubjectsUnited Kingdom
-
Nova Laboratories LimitedCompletedSickle Cell Disease | Sickle Cell Hemoglobin C | Sickle Cell-beta-thalassemia | Sickle-Cell; Hemoglobin Disease, ThalassemiaUnited Kingdom, Jamaica
-
CSL BehringCompletedCystic FibrosisBulgaria, Hungary, Poland, United Kingdom
-
NHS Blood and TransplantUniversity of York; British Medical Research CouncilTerminatedSickle Cell DiseaseUnited Kingdom
-
Vertex Pharmaceuticals IncorporatedActive, not recruitingAlpha-1 Antitrypsin DeficiencyUnited States, United Kingdom, Germany, Ireland
-
London North West Healthcare NHS TrustMedical Research Council CTUTerminatedSickle Cell DiseaseUnited Kingdom
-
Kamada, Ltd.CompletedEmphysemaUnited Kingdom, Canada, Denmark, Germany, Ireland, Netherlands, Sweden
-
PellePharm, Inc.CompletedBasal Cell Nevus SyndromeUnited Kingdom
-
SangartCompletedSickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | Hemoglobin SC Disease | Sickle Cell Disorders | Sickle Cell Hemoglobin C DiseaseUnited Kingdom, France, Jamaica, Lebanon
-
TakedaEnrolling by invitationAlpha1-Antitrypsin DeficiencyUnited Kingdom, Germany, United States, Austria, Portugal
-
Guy's and St Thomas' NHS Foundation TrustLondon School of Hygiene and Tropical Medicine; King's College London; King's... and other collaboratorsUnknownPregnancy, High Risk | Sickle Cell Disease | Blood Transfusion ComplicationUnited Kingdom
-
University of FloridaCompletedAlpha-1 Antitrypsin Deficiency | Liver Fibrosis | AATD | AAT DeficiencyUnited States
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyActive, not recruitingAlpha 1-Antitrypsin DeficiencyUnited Kingdom, United States, Ireland, Belgium, New Zealand, Spain, Netherlands, Portugal, Canada, Australia, France, Austria, Germany, Sweden